ñ

ñ

Menu Close

Why Omicron variant may resist COVID-19 Vaccines ─Researchers

*The US Centers for Disease Control and Prevention reviews data and presentations on the Johnson & Johnson vaccine, and recommends that consumers choose either the Moderna or Pfizer vaccine instead

Isola Moses | ñ

Researchers at Columbia University have published a study that suggests that the Coronavirus (COVID-19) Omicron variant is “markedly resistant” to vaccines – even booster shots.

The experts suggested the Omicron strain may be hard to check the spread of the mutation as it works its way around the world, agency report said.

The authors of the study wrote: “A striking feature of this variant is the large number of spike mutations that pose a threat to the efficacy of current COVID-19 vaccines and antibody therapies.”

They scientists point out that the variant’s “extensive” mutations can “greatly compromise” the vaccine, robbing it of its protective powers.

The study said a booster shot may provide “limited protection” against the new variant.

‘J&J vaccine provides little or no protection against Omicron’

The COVID-19 Vaccines produced by Johnson & Johnson and China’s Sinopharm, as well as the Russian-made Sputnik V, were found to provide little or no protection against the newly emerging Omicron variant, according to a study published during the week.

ñ learnt the latest study comes as COVID-19 cases are surging around the globe, appearing to be driven by the new Omicron variant.

The study, published as a preprint and is not yet peer-reviewed, discovered that just three out of 13 people who were fully vaccinated with China’s Sinopharm vaccine produced neutralising antibodies against Omicron.

According to the experts, one out of 12 people with the Johnson & Johnson vaccine exhibited neutralising antibodies.

However, none of the 11 with Russia’s Sputnik V vaccine revealed protection, per the study conducted by researchers at the University of Washington and Swiss drugmaker Humabs Biomed SA.

The study also found that the best protection against Omicron appears to come from both having a prior COVID-19 infection and two doses of a Pfizer vaccine.

Emerging data, also found that two doses of Pfizer’s vaccine are only marginally effective at preventing Omicron infection, and that booster shots are much more effective, Axios’ Caitlin Owens report said.

CDC advisers find issues with Johnson & Johnson vaccine

Meanwhile, an advisory committee to the Centers for Disease Control and Prevention (CDC) has reviewed data and presentations on the Johnson & Johnson vaccine, and is recommending that consumers choose either the Moderna or Pfizer vaccine instead.

It was gathered that the committee members were troubled by the possibility of rare but serious blood clotting that has been linked to the Johnson & Johnson vaccine.

The CDC immediately adopted the recommendations, report stated.

CDC Director Dr. Rochelle Walensky said: “Today’s updated recommendation emphasises CDC’s commitment to provide real-time scientific information to the American public.

“I continue to encourage all Americans to get vaccinated and boosted.”

According to researchers, vaccination plus infection equals ‘super immunity’ as far as combating the COVID-19 is concerned.

The scientists opined that there is some good news for fully vaccinated people who have recovered from a “breakthrough” case of COVID-19.

Researchers at Oregon Health and Science University emphasise that you may achieve “super immunity” against reinfection.

Their study found that people who had been vaccinated and then suffered a mild case of the virus had a lot more antibodies in their blood than those who had not been infected but were vaccinated.

The study finding is good news because it means the population will build up a strong immunity to future COVID-19 infection as more people get vaccinated and exposed to the virus, report said.

Coronavirus (COVID-19) ‌tally,‌ ‌as‌ ‌‌compiled‌‌ ‌by‌ ‌Johns‌ ‌Hopkins‌ ‌University indicates the total‌ ‌US‌ ‌confirmed‌ ‌cases as of Saturday, December 18, 2021, were 50,523,620 with total‌ ‌deaths estimated at 803,769 in the American country.

Also the total‌ ‌global‌ ‌cases were estimated at 273,130,047 and total‌ ‌global‌ ‌deaths put at ‌ 5,340,643 respectively.‌

Kindly Share This Story

 

Kindly share this story